S100A9 and cancer: Previous studies have shown that, over-expression of S100A9 in tumor stroma can inhibit the differentiation of dendritic cells and macrophages and induce accumulation of myeloid-derived suppressor cells, thus is partly responsible for immune defects in cancer [9, 10].